VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AVXLAnavex Life Sciences Corp.
$2.73$253M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAVXLEarnings History

AVXL logoAnavex Life Sciences Corp. (AVXL) Earnings History

Net Loss

22 years of earnings data (2004–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$40M
● Net Loss
TTM EPS (Diluted)
$-0.45
Per share, diluted
YoY EPS Growth
-3.8%
Slow
Net Margin
N/A
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating MarginN/A
Gross MarginN/A
Return on Equity-43.1%
Return on Assets-38.7%
Record Annual Net Income-$14,395FY2004
Record Quarterly EPS$0.04Q1 2014
Consecutive Profitable Years0years
Q1 2026
Net Income-$6M
EPS (Diluted)$-0.06
YoY Growth-3.8%Slow
QoQ Growth+42.2%Excellent

Loading earnings history...

Anavex Life Sciences Corp. (AVXL) Earnings Overview

As of June 21, 2026, Anavex Life Sciences Corp. (AVXL) reported trailing twelve-month net income of -$40M, reflecting -3.8% year-over-year growth. The company earned $-0.45 per diluted share over the past four quarters.

Looking at the long-term picture, AVXL's historical earnings data spans multiple years. The company achieved its highest annual net income of -$14,395 in fiscal 2004.

Anavex Life Sciences Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including SAVA (-$106M net income), PRAX (-$327M net income), ACAD ($376M net income, 36.5% margin), AVXL has comparable earnings metrics. Compare AVXL vs SAVA →

AVXL Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
AVXL logoAVXLCurrent
-$40M$-0.45--43.1%-3.8%—
SAVA logoSAVA
-$106M$-2.20--17.2%+77.6%
PRAX logoPRAX
-$327M$-11.31--45.8%-32.0%
ACAD logoACAD
$376M$2.1836.5%39.9%+68.4%
ATNM logoATNM
-$23M$-0.75-37652.2%-167.0%+14.2%
BIIB logoBIIB
$1.4B$9.2513.2%7.4%-21.1%
Best in group
Lowest in group

AVXL Historical Earnings Data (2004–2025)

22 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$46M-7.8%-$51M$-0.54--
2024-$43M+9.5%-$53M$-0.52--
2023-$48M+1.0%-$56M$-0.60--
2022-$48M-26.6%-$51M$-0.62--
2021-$38M-44.2%-$42M$-0.54--
2020-$26M+0.1%$0$-0.45--
2019-$26M-50.7%$0$-0.54--
2018-$17M-29.7%$0$-0.39--
2017-$13M+8.7%$0$-0.33--
2016-$15M-21.7%$0$-0.42--
2015-$12M-6.5%$0$-0.65--
2014-$11M-207.2%$0$-1.16--
2013-$4M+55.4%$0$-0.46--
2012-$8M-13.6%-$4M$-1.18--
2011-$7M+16.8%-$6M$-1.16--
2010-$9M-59.7%-$6M$-1.64--
2009-$5M-2.8%$0$-1.09--
2008-$5M-238.7%-$5M$-1.09--
2007-$2M-6088.3%-$2M$-0.33--
2006$-25,532+72.1%$-25,591$-0.01--
2005$-91,625-536.5%$-91,541$-0.02--
2004$-14,395-$0$-0.01--

Download Data

Export AVXL earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

22+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AVXL — Frequently Asked Questions

Quick answers to the most common questions about buying AVXL stock.

What is AVXL earnings per share (EPS)?

AVXL trailing twelve-month (TTM) diluted EPS is $-0.45, reflecting -3.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2004 to 2025 is available in the table on this page.

What is Anavex Life Sciences Corp.'s net income?

Anavex Life Sciences Corp. (AVXL) trailing twelve-month net income is $-40M as of 2025. Earnings declined -3.8% year-over-year.

Is AVXL profitable?

AVXL is not currently profitable on a TTM basis, reporting a net loss of $-40M. Net margin is N/A. Investors should monitor for a return to profitability.

What is AVXL's earnings growth rate?

AVXL compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2004 to 2025.

What are AVXL's profit margins?

Anavex Life Sciences Corp. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -43.1%.

Is AVXL growing earnings?

AVXL earnings growth is slowing. Current YoY EPS growth of -3.8% trails the 5-year CAGR of N/A. TTM net income is $-40M.

What was AVXL's best earnings year?

Anavex Life Sciences Corp.'s highest annual net income on record is $-14395.00, achieved in fiscal year 2004. Earnings history on this page spans 2004 to 2025 and includes all annual and quarterly figures.

What were AVXL's earnings last quarter?

AVXL's most recent reported quarter was Q1 2026. Net income was $-6M with diluted EPS of $-0.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.

AVXL Earnings Over Time (2004–2025)

Net income & EPS — annual and quarterly view